FREEZE-AFIB Post-Market Study
Diseases of the Cardiovascular System
What is the purpose of this trial?
This study is proposed herein is to gather clinical data on the safety and performance of the CRYOF device.
Specifically, data from this study will be used for submission to regulatory authorities in Europe, China and other geographies as needed.
- Ages18 years - 99 years
- Trial withAtriCure, Inc.
- Start Date06/21/2022
- End Date10/01/2022
- Last Updated11/11/2022
- Study HIC#2000031345